ADAM10 and glioblastoma: ADAM10-mediated cleavage of N-cadherin was associated with decreased glioblastoma cell migration, and its cleavage of ligands for the NK cell receptor NKG2D was shown to reduce the immunogenicity of GBM and hepatocellular carcinoma cells [10,16,17].